Collegium Pharmaceutical, Inc SEC filings COLL
Collegium Pharmaceutical, Inc has 870 filings in SEC EDGAR's recent list, going back to Oct 20, 2003. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 29, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Oct 19, 2026 | Oct 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 8, 2026 | — |
| 144 | Notice of proposed sale | Sep 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 24, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 144 | Notice of proposed sale | Jul 17, 2026 | — |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 8-K/A | Amended current report | Jun 30, 2026 | May 12, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| S-8 | Employee stock plan registration | Jun 1, 2026 | — |
| S-8 | Employee stock plan registration | Jun 1, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| 3 | Initial insider ownership | May 18, 2026 | May 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 144 | Notice of proposed sale | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 144 | Notice of proposed sale | May 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 8, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 7, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Mar 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 144 | Notice of proposed sale | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Dec 30, 2025 | Dec 23, 2025 |
| 144 | Notice of proposed sale | Dec 17, 2025 | — |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 6, 2025 |
| 144 | Notice of proposed sale | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Aug 29, 2025 |
| 144 | Notice of proposed sale | Aug 29, 2025 | — |
| 4 | Insider transaction | Aug 20, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 3 | Initial insider ownership | Aug 15, 2025 | Aug 7, 2025 |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 144 | Notice of proposed sale | Jul 8, 2025 | — |
| 144 | Notice of proposed sale | Jul 7, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 1, 2025 |
| 144 | Notice of proposed sale | Jul 2, 2025 | — |
| 144 | Notice of proposed sale | Jul 2, 2025 | — |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 POS | Filing | Jun 6, 2025 | — |
| S-8 | Employee stock plan registration | Jun 6, 2025 | — |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 3 | Initial insider ownership | May 19, 2025 | May 15, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 8-K |
Current report
Other events
|
May 12, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 28, 2025 | — |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| ARS | Annual report to shareholders | Mar 28, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 15, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 144 | Notice of proposed sale | Mar 21, 2025 | — |
| 144 | Notice of proposed sale | Mar 21, 2025 | — |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 3 | Initial insider ownership | Mar 19, 2025 | Mar 17, 2025 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Mar 18, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 17, 2025 | Mar 11, 2025 |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 144 | Notice of proposed sale | Mar 11, 2025 | — |
| 144 | Notice of proposed sale | Mar 11, 2025 | — |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 144 | Notice of proposed sale | Mar 7, 2025 | — |
| 144 | Notice of proposed sale | Mar 7, 2025 | — |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2025 | — |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 7, 2025 | — |
| 4 | Insider transaction | Feb 5, 2025 | Feb 4, 2025 |
| 3 | Initial insider ownership | Feb 5, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| 3 | Initial insider ownership | Nov 14, 2024 | Nov 12, 2024 |
| 8-K/A | Amended current report | Nov 14, 2024 | Sep 3, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 7, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 13, 2024 |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 4 | Insider transaction | Sep 6, 2024 | Sep 5, 2024 |
| 144 | Notice of proposed sale | Sep 6, 2024 | — |
| 144 | Notice of proposed sale | Sep 5, 2024 | — |
| 8-K |
Current report
Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Sep 4, 2024 | Sep 3, 2024 |
| S-8 | Employee stock plan registration | Aug 15, 2024 | — |
| 144 | Notice of proposed sale | Aug 12, 2024 | — |
| 144 | Notice of proposed sale | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Officer or director change, Regulation FD disclosure
|
Jul 29, 2024 | Jul 28, 2024 |
| 8-K |
Current report
Other events
|
Jun 13, 2024 | Jun 13, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Stoughton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1267565
- Former names
- COLLEGIUM PHARMACEUTICAL INC (until Mar 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.